Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Avalo Therapeutics, Inc. (AVTX)

NASDAQ

$16.15

$+0.09

(+0.57%)

Pre-Market

Avalo Therapeutics, Inc. (AVTX) Live Price Chart

Last updated: ⁦2026-09-16 10:31:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Avalo Therapeutics, Inc. (AVTX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $16.15, with a market capitalisation of $867.73M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $9.54 to $24.27. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$867.73M
Open	$16.06
Day's High	$9,331.20
Day's Low	$3.39
Previous Close	$16.07
Volume	5.27K
Average Volume	1.23M
P/E Ratio	--
52-Week High	$24.27
52-Week Low	$9.54
Dividend Yield	--
Earnings Date	--

Avalo Therapeutics, Inc. (AVTX) Pre-Market Stock Price

Avalo Therapeutics, Inc. (AVTX) is trading at $16.15 in pre-market trading as of 2026-09-16 09:46:00, up 0.51% ($0.08) from the previous close of $16.07

Pre-market trading shows how investors are pricing AVTX before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Avalo Therapeutics, Inc. (AVTX) 7-Day Stock Price Change

Over the past seven days, Avalo Therapeutics, Inc. (AVTX) moved from $19.23 to $16.15, representing a decline of 16.01% ($3.08).

The stock traded between $15.39 and $20.49 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 1.08 million shares, up versus the previous seven-day period, indicating higher trading activity.

AVTX 52-Week Price Position

Position in Range: 44.9%

52W Low$9.54

52W High$24.27

AVTX is currently trading at $16.15, placing it 44.9% of the way from its 52-week low of $9.54 to its 52-week high of $24.27. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Avalo Therapeutics, Inc. (AVTX)?

Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.

Avalo Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	33
Exchange	NASDAQ
Company Website	https://www.avalotx.com

How to Buy Avalo Therapeutics, Inc. (AVTX) Stock on MEXC

Eligible investors can buy real shares of Avalo Therapeutics, Inc. (AVTX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for AVTX and Place Your Order

Open the RealStocks trading page and search for AVTX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Avalo Therapeutics, Inc. (AVTX) stock price today?

Avalo Therapeutics, Inc. (AVTX) is currently trading at $ 16.15, up 0.51% ($0.08) from the previous close of $ 16.07. Intraday prices update in real time during regular trading hours.

2.Is AVTX stock going up or down today?

As of 2026-09-16 09:46:00, AVTX is trading at $ 16.15, up 0.51% ($0.08) from its previous close of $ 16.07. The stock has traded between $ 3.39 and $ 9,331.20 during today’s regular session. Past price movements do not guarantee future results.

3.What is AVTX pre-market price?

As of 2026-09-16 09:46:00, AVTX is trading at $ 16.15 in pre-market trading, up 0.51% ($0.08) from the previous close of $ 16.07. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is AVTX after-hours price?

As of 2026-09-16 09:46:00, AVTX is trading at $ 16.06 in after-hours trading, down 0.06% ($0.01) from the regular-session close of $ 16.07. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is AVTX stock trading now?

AVTX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does AVTX sit relative to its 52-week high and low?

Over the past 52 weeks, AVTX has traded between a low of $ 9.54 and a high of $ 24.27. At $ 16.15, the stock is positioned 44.9% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Avalo Therapeutics, Inc. in?

Avalo Therapeutics, Inc. (AVTX) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Avalo Therapeutics, Inc.'s market capitalisation and where is it listed?

Avalo Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 867.73M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is AVTX valued in terms of P/E ratio and EPS?

AVTX trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.87. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Avalo Therapeutics, Inc. pay a dividend?

Avalo Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.